###begin article-title 0
Association of mannose-binding lectin-2 genotype and serum levels with prognosis of sepsis
###end article-title 0
###begin title 1
Introduction
###end title 1
###begin p 2
Individuals deficient in mannose-binding lectin (MBL), an important component of the innate immune system, show increased susceptibility to infection. We investigated whether polymorphisms in the MBL2 gene and the serum level are associated with the severity and prognosis of sepsis.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 15 23 <span type="species:ncbi:9606">patients</span>
A total of 266 patients with sepsis and 398 healthy controls were enrolled. We analyzed the three single nucleotide polymorphisms (Gly54Asp, -550, and +4) in the MBL2 gene. Serum samples collected on day 1 were analyzed for the levels of MBL.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 146 148 146 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 259 261 259 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 457 459 455 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients who were heterozygous (A/B) or homozygous (B/B) at codon 54 (adjusted odds ratio (OR), 0.370; 95% confidence interval (CI), 0.207-0.661, P = 0.001) and who were heterozygous (H/L) or homozygous (L/L) at -550 (adjusted OR, 0.476; 95% CI, 0.249-0.910, P = 0.025) were less likely to have septic shock in the sepsis group. Using Cox regression analysis for 28-day mortality, an MBL level >/= 1.3 microg/mL showed significantly lower 28-day mortality (P = 0.020; hazard ratio, 0.571; 95% CI, 0.355-0.916) in the septic shock group.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
Homozygosity at codons 54 (A/A) and -550 (H/H) appears to be associated with the severity, but not the outcome, of sepsis, whereas a low MBL level may be an independent risk factor for mortality. These findings suggest that the genotype and serum level for MBL2 may have different clinical implications.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 237 247 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945; </italic>
###xml 337 338 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 339 340 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 341 342 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 686 687 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 846 848 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 849 851 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
Severe sepsis and septic shock cause 30% to 50% of all deaths in intensive care units (ICUs) [1]. Numerous studies have suggested that individuals vary in their ability to resist infection [2-4]. Genetic variations, such as those in the TNF-alpha alleles, have been implicated in determining the susceptibility to and outcome of sepsis [3,5-8]. The innate immune system is activated prior to the acquired immune system, and is thus the first line of defense against pathogens. The importance of the interactions between pathogen-associated microbial patterns and mannose-binding lectin (MBL) in activating innate immunity has been considered as a component of the innate immune system [9]. Moreover, it is now recognized that the first response to invasion (i.e., innate immunity) has a significant influence on the subsequent adaptive response [10,11].
###end p 10
###begin p 11
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
MBL is a calcium-dependent collagenous lectin present in serum. The high-molecular-weight oligomeric form of MBL binds carbohydrates on the surface of bacteria, fungi, and parasites. MBL then mediates activation of the complement cascade through MBL-associated serine proteases (MASP)-1 and -2, resulting in the destruction of microorganisms by opsonization and direct complement-mediated death [12-14].
###end p 11
###begin p 12
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 873 876 873 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 159 166 <span type="species:ncbi:9606">infants</span>
It has been reported that low concentrations of MBL cause defects in opsonization and phagocytosis that have been associated with recurrent infections in both infants and adults [15-17]. Low serum levels of MBL have been correlated with polymorphisms in the protein-coding region of MBL2 at codons 52, 54, and 57, which encode the variant alleles D, B, and C, respectively [18-20]. It was previously reported that two MBL2 polymorphisms (MBL-2 exon 1 and promoter -221) were associated with the development of sepsis, severe sepsis, and septic shock in Caucasian adults [21]. However, ethnic differences have been reported for both the promoter and structural variants, and large inter-individual variations in the level of MBL can be explained by the promoter variants [22]. Among Koreans, no polymorphisms in codons 52 and 57 have been reported, whereas polymorphisms in MBL2 at codons 54, -550 (promoter), and +4 (5'-UTR) have been associated with low MBL levels [23].
###end p 12
###begin p 13
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL</italic>
In this study, we investigated the relation between polymorphisms in MBL2 and the serum concentration of MBL, and assessed whether these polymorphisms influence the severity and prognosis of sepsis in a Korean population.
###end p 13
###begin title 14
Materials and methods
###end title 14
###begin title 15
Study population
###end title 15
###begin p 16
###xml 889 890 881 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 893 895 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 146 154 <span type="species:ncbi:9606">patients</span>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 493 501 <span type="species:ncbi:9606">patients</span>
###xml 1051 1063 <span type="species:ncbi:9606">participants</span>
Two hundred and sixty-six patients receiving intensive care for sepsis between 1 May, 2004 and 31 December, 2006 were enrolled in this study. All patients were managed according to our sepsis management protocol, which was guided by three full-time critical care physicians. All patients were older than 16 years of age (mean age +/- standard deviation, 61.6 +/- 14.7 years; male:female (M:F) = 169:97) and had been admitted to the ICU of a university-affiliated hospital in Seoul, Korea. The patients were divided into two groups: the severe sepsis group (mean age 61.6 +/- 16.9 years; M:F = 45:32) and the septic shock group (mean age 61.6 +/- 13.8 years; M:F = 124:65). The diagnosis of severe sepsis or septic shock was based on the criteria presented at the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference in 1992 [see Additional data file 1] [24]. As control subjects, 398 healthy blood donors (mean age 37.2 +/- 14.2 years; M:F = 219:179) were recruited. Informed consent was obtained from all study participants in accordance with the policies of the Institutional Review Board. This study was approved by the Institutional Review Board of the Asan Medical Center, Seoul, Korea.
###end p 16
###begin p 17
###xml 276 283 <span type="species:ncbi:9606">patient</span>
Clinical data, including demographic details, the Sequential Organ Failure Assessment (SOFA) score, the Acute Physiology, Age, and Chronic Health Evaluation II (APACHE II) score obtained at day one of severe sepsis or septic shock, and the ICU outcome, were recorded for each patient. Blood samples for MBL polymorphism and serum level were drawn within 24 hours of the onset of severe sepsis or septic shock
###end p 17
###begin title 18
Single nucleotide polymorphism genotyping
###end title 18
###begin p 19
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/B </italic>
###xml 325 329 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/L </italic>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P/Q </italic>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
We chose three single nucleotide polymorphism (SNPs; -550 in the promoter, +4 in the upstream region, and Gly54Asp in the coding region), which had previously exhibited an association with low MBL levels [23]. Genotyping was performed by PCR and sequencing, as previously described [25]. Haplotype analysis (A/B at codon 54, H/L at -550, and P/Q at +4) was performed to characterize the combined effects of the polymorphisms [26].
###end p 19
###begin p 20
The polymorphism of -550 in the promoter was amplified by PCR in a 302 bp fragment: forward primer 5'-TTGCCAGTGGTTTTTGACTC-3' and reverse primer 5'-GTATCTGGGCAGCTGATTCC-3'. The two polymorphisms of +4 in the upstream region and Gly54Asp were amplified by PCR in a 386 bp fragment: forward primer 5'-AGTCACGCAGTGTCACAAGG-3' and reverse primer 5'-AGAACAGCCCAACACGTACC-3'.
###end p 20
###begin title 21
Quantification of MBL by double antibody sandwich ELISA
###end title 21
###begin p 22
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
The serum MBL level was measured using a sandwich ELISA (MBL-ELISA; Dobeel, Gyeonggi, Korea) according to a previously established protocol [23].
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1286 1287 1286 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1287 1288 1287 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1294 1296 1294 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1864 1866 1864 1866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
The descriptive results of the continuous variables were expressed as medians with an interquartile range (IQR). All categorical data were compared using chi-squared analysis or a Fisher's exact test. Continuous data were compared using the Kruskal-Wallis or Mann-Whitney U tests. A receiver operating characteristic (ROC) curve was used to evaluate the cut-off values for the MBL level. A multiple stepwise logistic regression model was used to evaluate the prognostic value of the MBL level. The genotype frequencies were checked for consistency among cases and controls separately with those expected from the Hardy-Weinberg equilibrium [see Additional data file 2] using commercial software (SNP Alyze v 5.0; Dynacom, Yokohama, Japan). The association between cases and controls were examined by comparing allele and genotype frequencies in different groups of subjects using a chi-squared test. Allelic frequencies were compared between cases and controls using logistic regression to calculate age, gender-adjusted odds ratios (OR), and 95% confidence intervals (CI). Logistic regression analysis was also conducted to examine any significant association between polymorphism and disease phenotype (disease site and behavior). The pairwise linkage disequilibrium (LD) values, D', R2, and P values corresponding to chi-squared tests were calculated using the SNP Alyze software package (SNP Alyze v 5.0; Dynacom, Yokohama, Japan). The same software was used to estimate haplotypes and their frequencies. SNP Alyze software uses an expectation-maximization algorithm that determines the maximum-likelihood frequencies of multi-locus haplotypes in diploid populations. To examine differences in individual haplotype frequency and overall haplotype profiles between cases and controls, a permutation test was performed using the SNP Alyze software. In addition, P values were calculated by chi-squared statistics derived from simple two by two tables based on the frequency of each haplotype versus all others combined between cases and controls.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
Demographics of the subjects
###end title 26
###begin p 27
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 259 261 259 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
The characteristics of the patients at the time of admission are shown in Table 1. The overall mortality rate at 28 days was 31.4%. The severe sepsis group had a lower SOFA score and lower mortality rate compared with the septic shock group (10.6% vs. 39.7%; P < 0.001).
###end p 27
###begin p 28
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Baseline characteristics of the patients at day one of severe sepsis or septic shock
###end p 28
###begin p 29
###xml 71 73 71 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a </sup>
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </sup>
Data are presented as the median and interquartile range (25% to 75%). a = rheumatologic disease, inflammatory bowel disease; b = cellulitis, meningitis, leptospirosis.
###end p 29
###begin p 30
APACHE II = Acute Physiology, Age, and Chronic Health Evaluation II; ICU = intensive care unit; NS = not significant; SOFA = Sequential Organ Failure Assessment.
###end p 30
###begin title 31
The association of the MBL2 gene polymorphisms with sepsis susceptibility
###end title 31
###begin p 32
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/B</italic>
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B/B</italic>
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 273 276 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/L</italic>
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L/L</italic>
###xml 351 353 351 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P/Q </italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
Patients who were heterozygous (A/B) or homozygous (B/B) for the polymorphism at codon 54 (adjusted OR, 0.370; 95% CI, 0.207 to 0.661, P = 0.001) were less likely to have septic shock in the sepsis group (Table 2). Those patients in the sepsis group who were heterozygous (H/L) or homozygous (L/L) at -550 (adjusted OR, 0.476; 95% CI, 0.249 to 0.910, P = 0.025) were less likely to have septic shock (Table 3). The frequencies of P/Q at +4 were not significantly different among the three groups (data not shown).
###end p 32
###begin p 33
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Genotype frequencies for Gly54Asp in mannose-binding lectin between patients and controls and between septic patients
###end p 33
###begin p 34
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a </sup>
a = The adjusted OR was adjusted for age and gender. CI = confidence interval; OR = odds ratio.
###end p 34
###begin p 35
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Genotype frequencies for --550 in mannose-binding lectin between patients and controls and between septic patients
###end p 35
###begin p 36
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a </sup>
a = The adjusted OR was adjusted for age and gender. CI = confidence interval; OR = odds ratio.
###end p 36
###begin title 37
The association of serum MBL levels with the MBL2 genotypes
###end title 37
###begin p 38
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HH, HL</italic>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LL </italic>
###xml 157 163 157 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA, AB</italic>
###xml 169 172 169 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BB </italic>
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">QQ, PQ</italic>
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP </italic>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 600 606 600 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HL/LL </italic>
###xml 618 621 618 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP </italic>
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
The distribution of MBL concentrations was closely associated with the various MBL2 genotypes. The HH, HL, and LL genotypes of the -550 polymorphism and the AA, AB, and BB genotypes of the codon 54 polymorphism were correlated with high, medium, and low MBL levels, respectively, in all three groups, whereas the QQ, PQ, and PP genotypes of the +4 polymorphism were correlated with high, medium, and low MBL levels, respectively, only in the control group (Table 4). The serum MBL level was different among the three groups, even for subjects with the same genotype. Among the subjects with genotype HL/LL at -550 and PP at +4, the serum MBL level was higher for those in the septic shock group than for those in the severe sepsis group (Table 4).
###end p 38
###begin p 39
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mbl2 </italic>
Correlation of SNPs in the mbl2 gene with the serum MBL level
###end p 39
###begin p 40
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a </sup>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 267 269 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </sup>
###xml 271 273 271 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 303 305 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c </sup>
###xml 307 309 307 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Data are expressed as the median and interquartile range (IQR; 25% to 75%). a = P-value based on the Kruskal--Wallis or Mann--Whitney U test. Statistical differences in the mannose-binding lectin (MBL) levels were analyzed according to genotype within each subgroup. b = P < 0.05 vs. the control group. c = P < 0.05 vs. the severe sepsis group. SNP = single nucleotide polymorphism.
###end p 40
###begin p 41
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPA/HPA</italic>
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPA/LPA</italic>
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPA/LQA </italic>
###xml 252 260 252 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPA/LPA </italic>
###xml 381 383 381 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 495 503 495 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPA/LPA </italic>
###xml 506 514 506 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LPA/LQA </italic>
###xml 526 528 526 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 597 605 597 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPA/LPB </italic>
###xml 616 618 616 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
We next analyzed the haplotype profiles to characterize the combined effects of the three polymorphisms. HPA/HPA, HPA/LPA, and HPA/LQA were high MBL-producing haplotypes, and their frequencies were similar among the three groups. For subjects with the HPA/LPA haplotype, the serum MBL level was higher for those in the septic shock group than for those in the severe sepsis group (P < 0.05). The serum MBL level in the control group was higher than the severe sepsis group for subjects with the HPA/LPA or LPA/LQA haplotypes (P < 0.05) and lower than the severe sepsis group for subjects with the HPA/LPB haplotype (P < 0.05) (Figure 1).
###end p 41
###begin p 42
###xml 181 183 181 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 213 221 213 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPA/LPA </italic>
###xml 317 319 317 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 349 357 349 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPA/LPB </italic>
###xml 433 441 433 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LPA/LQA </italic>
###xml 600 602 600 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Comparison of serum MBL levels in various haplotypes in the three groups. The serum MBL level in the severe sepsis group was lower than the control group or the septic shock group (P < 0.05) for subjects with the HPA/LPA haplotype (a). The serum MBL level in the control group was lower than the severe sepsis group (P < 0.05) for subjects with the HPA/LPB haplotype (b) and higher than the severe sepsis group for subjects with the LPA/LQA haplotypes (c). Haplotype estimation was performed using Arlequin software. The median mannose-binding lectin (MBL) levels are indicated by horizontal bars. * P < 0.05 between the two groups.
###end p 42
###begin title 43
The association of serum MBL levels with outcome
###end title 43
###begin p 44
###xml 91 93 90 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 466 468 462 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 972 973 962 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 566 574 <span type="species:ncbi:9606">patients</span>
The serum MBL level in the septic shock group (1.85 mug/mL; IQR, 0.87 to 2.67) was higher (P < 0.05) than the severe sepsis (0.78 mug/mL; IQR, 0.39 to 1.37) or control groups (1.36 mug/mL; IQR, 0.39 to 2.74); however, the serum MBL level was not significantly different between the severe sepsis and control groups. Subgroup analysis of the septic shock group indicated that the survivors in this group (2.18 mug/mL; IQR, 1.15 to 2.95) had a higher serum MBL level (P < 0.05) than the non-survivors (1.37 mug/mL; IQR, 0.49 to 2.05) (Figure 2). We divided the septic patients into two groups according to serum MBL levels (MBL <1.3 mug/mL and MBL >/= 1.3 mug/mL) using a ROC curve. There was no difference in frequency for Gram-positive or Gram-negative infection depending on the MBL deficiency. According to the Cox proportional hazards model, a low MBL level (<1.3 mug/mL) was an independent risk factor for mortality after 28 days within the septic shock group (Figure 3).
###end p 44
###begin p 45
###xml 53 61 <span type="species:ncbi:9606">patients</span>
The serum MBL levels in the control group and in the patients with severe sepsis and septic shock. The serum mannose-binding lectin (MBL) level in the septic shock group was higher than the severe sepsis or control group. The survivors had a higher serum MBL level than the nonsurvivors in the septic shock group. Data are expressed as the median and interquartile range (IQR). The box represents the median and IQR (25% to 75%) and the error bar represents the IQR (10% to 90%).
###end p 45
###begin p 46
###xml 341 343 337 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 549 551 544 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 148 156 <span type="species:ncbi:9606">patients</span>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
Kaplan-Meier survival curve for septic patients at 28 days according to the MBL level. (a) The difference for 28-day mortality was not found in all patients according to serum MBL levels (MBL <1.3 mug/mL and MBL >/= 1.3 mug/mL). (b) In subgroup analysis, the difference for 28-day mortality within septic shock patients was more pronounced (P = 0.020). A low MBL level (<1.3 mug/mL) was an independent risk factor for mortality after 28 days within the septic shock group. There was a hazard ratio of 0.571 (95% confidence interval, 0.355 to 0.916; P = 0.020) in the Cox proportional hazards model correcting for age, sex, and comorbidities. MBL = mannose-binding lectin.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 153 161 <span type="species:ncbi:9606">patients</span>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
Our study shows that two polymorphisms in MBL2 (at codons 54 in exon 1 and -550 in the promoter) may be associated with the severity of sepsis in Korean patients; however, these polymorphisms were not associated with mortality. The serum MBL level was associated with increased risk for mortality after 28 days in the patients with septic shock as found in previous studies [21,27]. However, the serum MBL level was not determined through the known polymorphisms of MBL in the septic condition.
###end p 48
###begin p 49
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 335 338 335 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y/X</italic>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 54 61 <span type="species:ncbi:9606">infants</span>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
###xml 493 501 <span type="species:ncbi:9606">patients</span>
MBL deficiency has been associated with infections in infants and in patients with concomitant immunodeficiencies [15,28,29]. Recent studies have reported that the frequency of MBL-variant alleles is increased with the severity of sepsis [21,27,30]. The functionality of the MBL-2 exon 1 and promoter polymorphisms at -221 G/C, termed Y/X, has been well documented in Caucasian patients [22,31,32]. To examine the importance of MBL-variant alleles in the susceptibility to sepsis among Korean patients, we analyzed three polymorphisms (-550, Gly54Asp, and +4) that had previously exhibited significant correlations with the serum MBL level [23].
###end p 49
###begin p 50
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/A</italic>
###xml 205 208 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
In the present study, the genotypes of individual SNPs were not independently associated with the development of sepsis. However, homozygosity for the MBL2 structural genotype (A/A) and the -550 genotype (H/H) was associated with the progression from severe sepsis to septic shock. Due to selective pressure promoting heterozygosity, a heterozygous advantage (heterosis) of the MBL2-variant alleles has been proposed [19,33]. The high frequency of MBL-variant alleles in different populations indicates that these polymorphisms represent a balanced genetic system favoring variant alleles arising from genetic selection. Thus, the normal A allele may confer disadvantages to the host under some circumstances, such as sepsis [34]. Although heterozygosity associated with a low MBL level showed an advantage for severity in the sepsis, there was no demonstrable influence on outcome. Accordingly, MBL polymorphisms may play a key role in the severity of sepsis, but they are not a determinant of the outcome.
###end p 50
###begin p 51
###xml 534 539 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 650 655 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
In contrast, the serum MBL level in response to sepsis seems to be related to the outcome. A MBL level of 1.3 mug/mL or more was an independent factor in the survival of septic shock. However, among patients with the same haplotypes, the serum MBL level was different depending on the clinical setting. This suggests that other factors, such as cytokine levels or other alleles moving in tight linkage disequilibrium, may affect the level of MBL during sepsis. These findings may help explain why, despite the strong relation between MBL2 genetic variants and susceptibility to septic shock, there is no evidence to date showing the influence of the MBL2 genotype on clinical outcome.
###end p 51
###begin p 52
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
Using MBL2 genotype analysis, several studies have shown variations in ethnic-specific genetic structure as well as non-genetic factors [18-20,27]. However, the observation that a deficiency in the amount of functional MBL increases the severity of sepsis has been made repeatedly [27,30]. Therefore, measuring the serum MBL level may be important for the prognosis of septic patients in a clinical setting.
###end p 52
###begin p 53
###xml 497 499 497 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
There were certain limitations to the present study. It has been reported that two promoter polymorphisms -550 and -221, and coding variants at codon 52, 54, and 57 of the MBL gene affect the MBL protein level in various populations. In more than 100 Korean controls, the codon 52 and 57 polymorphisms were not present and the effect of the -550 promoter SNP on MBL levels was stronger than that of the -221 promoter SNP. The effect of the X allele at -221 did not reach statistical significance (P = 0.156) in the correlation between MBL genotypes and MBL serum levels [23]. This could be because of the low frequency of the X allele in Koreans, 0.11, compared with 0.195 in the Danish population. As we screened only three known polymorphisms based on these results, we cannot rule out the possibility that the observed differences in MBL concentration are at least partially under the influence of additional polymorphisms. In addition, without examining family samples for inheritance patterns, the accuracy of this method of inference is unknown.
###end p 53
###begin p 54
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/A</italic>
###xml 454 457 454 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</italic>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 182 190 <span type="species:ncbi:9606">patients</span>
###xml 545 553 <span type="species:ncbi:9606">patients</span>
Another limitation of our study was that we did not evaluate patients without sepsis, such as patients with noninfectious systemic inflammatory response syndrome. If we had included patients with noninfectious systemic inflammatory response syndrome, we may have been able to explain our results more clearly and provide more support for the suggestion that there is an association of the homozygous MBL2 structural genotype (A/A) and the -550 genotype (H/H) with the progression from severe sepsis to septic shock. However, there were very few patients without infection or with sepsis without organ failure admitted to the medical ICU of the tertiary referral hospital.
###end p 54
###begin p 55
Moreover, we measured MBL levels only once within the initial 24 hours of the septic course. This single measurement may reduce the power of the MBL level in terms of a prognostic factor. In addition, certain confounding factors, such as treatment and duration of illness before admission to the ICU, were not included in our analysis.
###end p 55
###begin title 56
Conclusions
###end title 56
###begin p 57
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 236 241 236 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 125 132 <span type="species:ncbi:9606">patient</span>
Our results showed that the genotype and serum level for MBL2 may have different clinical implications, and suggest that the patient with high MBL2 production responding to a bacterial invasion may have better prognosis irrespective of MBL2 gene polymorphism.
###end p 57
###begin title 58
Key messages
###end title 58
###begin p 59
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/A</italic>
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</italic>
* Homozygosity for the MBL2 structural genotype (A/A) and the -550 genotype (H/H) was associated with the progression from severe sepsis to septic shock.
###end p 59
###begin p 60
###xml 82 84 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
* An MBL level of 1.3 mug/mL or more showed significantly lower 28-day mortality (P = 0.020; hazard ratio, 0.571; 95% CI, 0.355 to 0.916) in the septic shock group.
###end p 60
###begin p 61
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 </italic>
* The genotype and serum level for MBL2 may have different clinical implications.
###end p 61
###begin title 62
Abbreviations
###end title 62
###begin p 63
APACHE: Acute Physiology and Chronic Health Evaluation; bp: base pair; CI: confidence interval; ELISA: enzyme-linked immunosorbent assay; ICU: intensive care unit; IQR: interquartile range; MASP: MBL-associated serine proteases; MBL: mannose-binding lectin; M:F: male;female; OR: odds ratio; PCR: polymerase chain reaction; ROC: receiver operator characteristic; SNP: single nucleotide polymorphism; SOFA: Sequential Organ Failure Assessment; TNF: tumor necrosis factor.
###end p 63
###begin title 64
Competing interests
###end title 64
###begin p 65
The authors declare that they have no competing interests.
###end p 65
###begin title 66
Authors' contributions
###end title 66
###begin p 67
###xml 61 68 <span type="species:ncbi:9606">patient</span>
HJW and KYS initiated the study. LCM and HSB participated in patient management. HJW, SKY and YJS analyzed the data. All the authors contributed to read and approved the final manuscript.
###end p 67
###begin title 68
Supplementary Material
###end title 68
###begin title 69
Additional file 1
###end title 69
###begin p 70
Word file containing a table that lists the Criteria of sepsis, severe sepsis, and septic shock used in our research.
###end p 70
###begin p 71
Click here for file
###end p 71
###begin title 72
Additional file 2
###end title 72
###begin p 73
###xml 118 126 <span type="species:ncbi:9606">patients</span>
Word file containing a table that lists the Hardy-Weinberg-test for the study population (healthy controls and septic patients).
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Acknowledgements
###end title 75
###begin p 76
We thank YY Park and EM Jo for technical expertise and assistance and JY Lim for data management.
###end p 76
###begin article-title 77
Epidemiology of sepsis: an update
###end article-title 77
###begin article-title 78
Genetic dissection of the molecular pathogenesis of severe infection
###end article-title 78
###begin article-title 79
Genetic and environmental influences on premature death in adult adoptees
###end article-title 79
###begin article-title 80
Common west African HLA antigens are associated with protection from severe malaria
###end article-title 80
###begin article-title 81
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
###end article-title 81
###begin article-title 82
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis
###end article-title 82
###begin article-title 83
Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy
###end article-title 83
###begin article-title 84
Genetic determinants influencing the response to injury, inflammation, and sepsis
###end article-title 84
###begin article-title 85
Mannose-binding lectin: structure, function, genetics and disease associations
###end article-title 85
###begin article-title 86
Immunomodulation and sepsis: impact of the pathogen
###end article-title 86
###begin article-title 87
Bacterial recognition and induced cell activation in sepsis
###end article-title 87
###begin article-title 88
The lectin-complement pathway--its role in innate immunity and evolution
###end article-title 88
###begin article-title 89
Mannose-binding lectin deficiency--revisited
###end article-title 89
###begin article-title 90
The role of mannose-binding lectin in health and disease
###end article-title 90
###begin article-title 91
Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood
###end article-title 91
###begin article-title 92
Association of low concentrations of serum mannose-binding protein with recurrent infections in adults
###end article-title 92
###begin article-title 93
Mannose binding protein gene mutations associated with unusual and severe infections in adults
###end article-title 93
###begin article-title 94
###xml 53 61 <span type="species:ncbi:9606">children</span>
Molecular basis of opsonic defect in immunodeficient children
###end article-title 94
###begin article-title 95
High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene
###end article-title 95
###begin article-title 96
###xml 80 85 <span type="species:ncbi:9606">human</span>
A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein
###end article-title 96
###begin article-title 97
Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome
###end article-title 97
###begin article-title 98
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
###end article-title 98
###begin article-title 99
Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the Korean population
###end article-title 99
###begin article-title 100
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine
###end article-title 100
###begin article-title 101
Characterization of publicly available SNPs in the Korean population
###end article-title 101
###begin article-title 102
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome
###end article-title 102
###begin article-title 103
###xml 18 21 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin
###end article-title 103
###begin article-title 104
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis
###end article-title 104
###begin article-title 105
###xml 83 91 <span type="species:ncbi:9606">patients</span>
Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin
###end article-title 105
###begin article-title 106
Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers
###end article-title 106
###begin article-title 107
###xml 44 49 <span type="species:ncbi:9606">human</span>
Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype
###end article-title 107
###begin article-title 108
###xml 136 144 <span type="species:ncbi:9606">patients</span>
Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients
###end article-title 108
###begin article-title 109
Dual role of mannan-binding protein in infections: another case of heterosis?
###end article-title 109

